82 related articles for article (PubMed ID: 21997313)
1. HER2 codon 655 G-allele is associated with reductions in plasma high-density lipoprotein levels in breast cancer patients treated with tamoxifen.
Chang NW; Chen DR; Chen FN; Lin C; Wu CT
J Investig Med; 2011 Dec; 59(8):1252-7. PubMed ID: 21997313
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E4 allele influences the response of plasma triglyceride levels to tamoxifen in breast cancer patients.
Chang NW; Chen FN; Wu CT; Lin CF; Chen DR
Clin Chim Acta; 2009 Mar; 401(1-2):144-7. PubMed ID: 19103187
[TBL] [Abstract][Full Text] [Related]
3. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
Wasan KM; Ramaswamy M; Haley J; Dunn BP
J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
[TBL] [Abstract][Full Text] [Related]
4. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
[TBL] [Abstract][Full Text] [Related]
5. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
[TBL] [Abstract][Full Text] [Related]
6. The influence of HER2 genotypes as molecular markers on breast cancer outcome.
Mutluhan H; Akbas E; Erdogan NE; Soylemez F; Senli MS; Polat A; Helvaci I; Seyrek E
DNA Cell Biol; 2008 Oct; 27(10):575-9. PubMed ID: 18721072
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?
Gaibar M; Fernández G; Romero-Lorca A; Novillo A; Tejerina A; Bandrés F; Fernández-Santander A
Int J Biol Markers; 2013 Dec; 28(4):e371-6. PubMed ID: 23828408
[TBL] [Abstract][Full Text] [Related]
8. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
Gouni-Berthold I; Giannakidou E; Faust M; Berthold HK; Krone W
Atherosclerosis; 2005 Dec; 183(2):336-41. PubMed ID: 16285997
[TBL] [Abstract][Full Text] [Related]
10. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Dec; 35(12):6667-70. PubMed ID: 26637882
[TBL] [Abstract][Full Text] [Related]
11. Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition.
Bagdade JD; Wolter J; Subbaiah PV; Ryan W
J Clin Endocrinol Metab; 1990 Apr; 70(4):1132-5. PubMed ID: 2318936
[TBL] [Abstract][Full Text] [Related]
12. Effect Of Tamoxifen On Plasma Lipid Profile In Patients Of Breast Cancer.
; Haider G; Shaikh Z; Kumar P; Memon P; Rahul R; Parkash J; Nouman M; Ahmed K; Shaikh MR
J Ayub Med Coll Abbottabad; 2023; 35(4):558-562. PubMed ID: 38406935
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
Naidu R; Yip CH; Taib NA
Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients.
Kara N; Karakus N; Ulusoy AN; Ozaslan C; Gungor B; Bagci H
DNA Cell Biol; 2010 Jul; 29(7):387-92. PubMed ID: 20380571
[TBL] [Abstract][Full Text] [Related]
15. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
Tominaga T; Kimijima I; Kimura M; Takatsuka Y; Takashima S; Nomura Y; Kasumi F; Yamaguchi A; Masuda N; Noguchi S; Eshima N
Jpn J Clin Oncol; 2010 Jul; 40(7):627-33. PubMed ID: 20382637
[TBL] [Abstract][Full Text] [Related]
16. Effects of tamoxifen therapy on plasma lipid profile in patients of breast cancer.
Gupta S; Tandon VR; Kapoor B; Gupta A; Gupta GD; Khajuria V
J Assoc Physicians India; 2006 Mar; 54():183-6. PubMed ID: 16800341
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
Ilanchezhian S; Thangaraju M; Sachdanandam P
Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
[TBL] [Abstract][Full Text] [Related]
19. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
[TBL] [Abstract][Full Text] [Related]
20. [The association study of the LIPC -250g/A polymorphism and high-carbohydrate/low-fat diet induced serum lipid and apolipoprotein concentration changes in healthy youth].
Hu MS; Li ZK; Fang DZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):727-30, 735. PubMed ID: 24325099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
